Stay updated with breaking news from Breakthrough Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PALO ALTO, Calif., Jan. 4, 2024 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. , a commercial-stage biopharmaceutical company focused on the development of innovative therapies for rare metabolic...
Company well-positioned for further progress and broadening of R&D pipelineCash resources of approximately $455 million as of December 31, 2023 Expected cash runway, including proceeds from recent...
Preliminary total 4Q and full year 2023 net product revenue of $71 million and $204 million, respectively Auvelity preliminary 4Q and full year 2023 net product sales of $49 million and $130 million,...
– ARCALYST® 2023 net product revenue grew ~90% year-over-year to $233.1 million – – ARCALYST 2024 net product revenue expected to be $360 - $380 million – – Abiprubart Phase 2...
FOSTER CITY, Calif., Jan. 03, 2024 -- Apollomics Inc. , a clinical-stage biopharmaceutical company developing medicines to address difficult-to-treat cancers, today announced the completion of...